ArticleACS chemical neuroscience2026
Fragmentation-Induced Disassembly and Reaggregation of α-Synuclein Amyloid Fibrils.
Article in ACS chemical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aggregation of the protein α-synuclein (α-syn) is a defining pathological characteristic of Parkinson's disease (PD). Kinetic studies have provided increasingly detailed insights into the mechanisms of α-syn aggregation, highlighting the contributions of secondary nucleation and elongation to fibril growth. However, the understanding of the role of fibril breakage (fragmentation) remains sparse. We therefore established a modified thioflavin-T (ThT) kinetic assay in which ultrasonication steps were introduced when the conversion of α-syn monomers into amyloid fibrils had reached the plateau. This triggered, expectedly, fibril fragmentation but also rapid partial dissociation of the α-syn fibrils and subsequent elongation-dominated fibril regrowth, the kinetics of which could be monitored by ThT and were found to proceed until steady state was reestablished. Interestingly, the regrowth of α-syn variants A30P, E46K, and A53T, but not wild type or variant H50Q, resulted in significant increases in ThT fluorescence even though the residual monomer concentration at steady state was unaffected and no new monomers were added to the assayed systems. Furthermore, for these variants, which are all associated with early-onset PD, the residual monomer concentration was consistently higher than for wild-type α-syn and the late-onset variant H50Q, suggesting differences in monomer-fibril equilibria. Altogether, our study shows that α-syn amyloid fibrils are capable of undergoing structural evolution of a type that alters their ThT binding, highlights the role of fragmentation in expediating such maturation processes, and points out a putative connection between propensity of structural conversion, decreased fibril stability, and early onset of Parkinson's disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.